Alternatively, RIPK1 inhibition in a murine collagen-induced arthritis model was able to reduce proinflammatory cytokine expression of IL-17, IL-1β, IL-6, and TNFα, suggesting that RIPK1 inhibition has the potential to impact myeloid and T cell responses (77). The gene discussed is RIPK1; the disease is arthritic joint disease.